SELLAS Life Sciences Group, Inc. SLS
8.42 USD +0.05 (+0.60%)
At closeNov 11, 2026, 6:04 PM EST
8.35 -0.07 -0.83%
After hours · Nov 11, 6:04 PM ET
8.09 Day range 8.59
1.39 52-week range 15.88
- YTD
- +123.34%
- 1 year
- +457.62%
News
benzinga.com SELLAS Life Sciences To Present Data From Completed Phase 2 Study Of SLS009 For Treatment Of R/R AML, At 68th ASH Annual Meeting And Exposition − Company to present Phase 2 clinical data evaluating SLS009 (tambiciclib) in combination with azacitidine and venetoclax in patients who have previously failed venetoclax-based therapy − − Patients…
globenewswire.com SELLAS Life Sciences to Present Positive Phase 2 Data Demonstrating Encouraging Response and Survival Outcomes with SLS009 Combination in High-Risk AML at ASH 2026 − Company to present Phase 2 clinical data evaluating SLS009 (tambiciclib) in combination with azacitidine and venetoclax in patients who have previously failed venetoclax-based therapy − − Patients…
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Pulmonx (NASDAQ:LUNG) stock increased by 33.1% to $2.63 during Wednesday's regular session. The company's market cap stands at $85.0 million. As per the press release, Q3 earnings came out…
benzinga.com SELLAS Life Sciences Stock Stumbles: What's Going On? SELLAS Life Sciences Group shares are falling Wednesday as the company's Phase 3 leukemia study moves toward its final analysis.
benzinga.com SELLAS Life Sciences Announces Its Pivotal Phase 3 Study Of Galinpepimut-S In Acute Myeloid Leukemia Participants Surpasses Pre-Specified 80th Event SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS’’ or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer
benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com SELLAS Life Sciences Announces Preclinical Data Demonstrating SLS009 Synergy And Activity In MYC-Amplified Pancreatic Cancer Models SLS009 increased apoptosis more than six-fold versus daraxonrasib in a MYC-amplified, daraxonrasib-resistant patient-derived pancreatic cancer organoid model - Combination of SLS009 and daraxonrasib…
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) stock moved upwards by 44.6% to $2.4 during Monday's pre-market session. The company's market cap stands at $1.1 million. Definium Therapeutics…- benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com SELLAS Life Sciences Says Three Abstracts Evaluating SLS009, Potent, Selective CDK9 Inhibitor, In Preclinical Models Of PDAC Accepted For Poster Presentation At AACR Conference On Pancreatic Cancer - Three posters to highlight preclinical activity of SLS009 (tambiciclib) across patient-derived KRAS mutant organoid models of pancreatic cancer – - Studies conducted in collaboration with the…
benzinga.com SLS Stock Looks Like a $3 Billion Biotech Winner—This Short Seller Says the Market Has It Dangerously Wrong: 'Most Expensive Coin Flip' (UPDATED) Short seller BMF Capital disclosed a short position in SELLAS Life Sciences, arguing the market has 'dangerously overvalued' the biotech.
benzinga.com Benzinga Bulls and Bears: Nvidia, CrowdStrike, Intuit Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.
benzinga.com When Revolution Medicines' FDA Win Lifts Other Boats: SELLAS Life Sciences Stock Surges SELLAS stock gains momentum following FDA approval for Revolution Medicines, highlighting SLS009 preclinical pancreatic cancer data.- benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…- benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com SELLAS Life Sciences Gr Q2 EPS $(0.05) Misses $(0.04) Estimate SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.04) by 25 percent. This is a 28.57 percent increase over losses…- benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers Jasper Therapeutics (NASDAQ:JSPR) stock moved upwards by 19.2% to $0.92 during Friday's regular session. The company's market cap stands at $21.6 million. Kalaris Therapeutics (NASDAQ:KLRS)…
benzinga.com ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On Friday US stocks lower, Nasdaq falls 400 pts. ManpowerGroup shares rise after upbeat earnings. Other big gainers: PHOE, SG, TRVI, DCBO, ZNTL, GPRE, SLS, FEIM, TRV, BHVN, KOS, BJRI, MBX.
benzinga.com SELLAS Life Sciences Shares Slip Wednesday as Price Tests $16 Resistance Wall SELLAS Life Sciences Group shares are trading lower Wednesday as investors take profits, with risk appetite softer across equities.
benzinga.com SELLAS Life Sciences Shares Fall Tuesday: What's Driving The Move? SELLAS Life Sciences shares are trading lower Tuesday as traders digest a breakout run, with momentum still elevated from the latest update.
benzinga.com Sellas Life Sciences Shares Break Out To New 52-Week High: What's Driving The Momentum? SELLAS Life Sciences shares are trading higher by about 24% on Monday as the stock extends a breakout run that has traders focused on fresh highs and corporate updates.- benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Iridium Communications, FuelCell Energy, Rocket Lab And Other Big Stocks Moving Higher On Monday Dow Jones gains 350 points, Iridium acquired by Rocket Lab for $8B, big stocks recording gains: QuidelOrtho, FuelCell, Ouster, Viasat, Swarmer, Charter, Prime Medicine, Roblox, Satellogic, Churchill…
benzinga.com SELLAS Stock Hits New Highs: What's Happening Today? SELLAS Life Sciences Group Inc (NASDAQ: SLS) shares are pushing higher Friday morning, extending Thursday’s strong rally.
benzinga.com Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On Friday Apogee Enterprises Inc (NASDAQ: APOG) rose sharply after the company reported better-than-expected first-quarter financial results. Other big gainers in today's session include FuelCell Energy Inc…
benzinga.com Why SELLAS Life Sciences Stock Is Surging Thursday Shares of SELLAS Life Sciences Group are rallying Thursday, hitting a fresh 52-week high of $11.06 on heavy volume after a regulatory filing.- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Atlantic International (NASDAQ:ATLN) shares increased by 41.0% to $1.1 during Thursday's regular session. The company's market cap stands at $59.4 million. As per the press release, Q1…
benzinga.com Jim Cramer: Buy GE Aerospace, 'Two Thumbs Up' For This Life Sciences Stock On Mad Money Lightning Round, Cramer likes Joby Aviation for its spec and US gov. investment in drones. Recommends buying QXO, GE, and BTC.- benzinga.com 10 Health Care Stocks With Whale Alerts In Today's Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com TAT Technologies Posts Upbeat Q1 Earnings, Joins Roivant Sciences, Immunitybio And Other Big Stocks Moving Higher On Wednesday TAT Technologies Ltd (TATT) reported better-than-expected Q1 results, sending shares up 11.7%. Other big gainers include IMVT, SLS, TE, VUZI, ROIV, POET, ARM, AMC, ALAB, DSGN, and TLN.
benzinga.com SELLAS Life Sciences Stock Is Surging Wednesday: What's Driving The Move? Sellas Life Sciences shares are rising Wednesday after its latest update on acute myeloid leukemia pipeline and Phase 3 readout timeline.
benzinga.com Vishay Intertechnology, Eos Energy Enterprises, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday Vishay Intertechnology (VSH) stock up 10%, Velo3D (VELO) up 35.5%, VNET (VNET) up 32.5%, C4 Therapeutics (CCCC) up 19.4%, Kingsoft Cloud (KC) up 18.6%, Tower Semiconductor (TSEM) up 17.5%, Nebius…
benzinga.com SELLAS Life Sciences Nears Pivotal Trial Readout As Leukemia Pipeline Progresses SELLAS Life Sciences reports wider Q1 loss as REGAL Phase 3 AML trial nears key data readout and SLS009 advances in early-line studies.- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why Nextpower Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket Nextpower Inc (NXT) shares rose in pre-market trading after reporting strong Q4 results, raising sales guidance, and announcing an acquisition.
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session 
benzinga.com SELLAS Life Sciences Gr Q1 EPS $(0.05) Beats $(0.06) Estimate SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 28.57 percent increase over losses…
benzinga.com XOMA Royalty, Oruka Therapeutics, Repay Holdings And Other Big Stocks Moving Higher On Monday U.S. stocks were lower, Dow Jones fell 0.1% on Monday. XOMA shares rose on Ligand's plans to acquire XOMA for $39.00/share. Other big gainers: MANE, ORKA, OGN, XE, PLBL, SLS, ANAB, EVH, IHRT, RPAY,…- benzinga.com 10 Health Care Stocks With Whale Alerts In Today's Session
- benzinga.com SELLAS Life Sciences Gr Q4 EPS $(0.05) Beats $(0.07) Estimate SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 37.5 percent increase over losses…
- benzinga.com SELLAS Life Sciences Group To Reveal Preclinical Data On SLS009 In A Poster Session At The American Association For Cancer Research Taking Place April 17-22 At San Diego Convention Center In San Diego, CA SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS'' or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer…
- benzinga.com 10 Health Care Stocks Whale Activity In Today's Session
benzinga.com What's Going With SELLAS Life Sciences Stock On Wednesday? SELLAS Life Sciences stock jumps over 200% in six months as cancer trial updates boost momentum and short interest tops 27%.- benzinga.com 10 Health Care Stocks Whale Activity In Today's Session
- benzinga.com SELLAS Life Sciences Enters Into Agreement With IMPACT-AML To Launch European Clinical Study Of SLS009 Supports capital-efficient expansion of the SLS009 clinical program into frontline AML, enabling broader U.S. and European patient enrollment U.S. enrollment evaluating SLS009 in combination with…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session